Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury

Brain, Behavior, and Immunity

Volumn 53, Issue , 2016, Pages 183-193

  Kumar, Raj G ^a   Rubin, Jonathan E ^b   Berger, Rachel P ^a,c   Kochanek, Patrick M ^a,c   Wagner, Amy K ^a,b,c  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Cluster analysis; Cytokines; Inflammation; Interleukins; Outcome; Principal component analysis; Prognosis; Rehabilomics; Soluble cell surface markers; TBI

Indexed keywords

BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; ESTRADIOL; FAS ANTIGEN; HYDROCORTISONE; INTERLEUKIN 10; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; PROGESTERONE; PROTEIN S100B; TESTOSTERONE; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; INTERLEUKIN DERIVATIVE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CEREBROSPINAL FLUID LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; PROTEIN BLOOD LEVEL; SURVIVOR; TRAUMATIC BRAIN INJURY; BLOOD; CEREBROSPINAL FLUID; CLUSTER ANALYSIS; COHORT ANALYSIS; FORECASTING; MIDDLE AGED; PREDICTIVE VALUE; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; BIOMARKERS; BRAIN INJURIES, TRAUMATIC; CLUSTER ANALYSIS; COHORT STUDIES; CYTOKINES; FEMALE; FORECASTING; GLASGOW OUTCOME SCALE; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERLEUKINS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PRINCIPAL COMPONENT ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVIVORS;

EID: 84959571904     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.12.008     Document Type: Article

References (52)

1. Baker S.P., O'Neill B., Haddon W., Long W.B. The injury severity score: a method for describing patients with multiple injuries and evaluating emergency care. J. Trauma 1974, 14:187-196.
2. Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons Guidelines for the management of severe traumatic brain injury. J. Neurotrauma 2007, 24(Suppl. 1). S1-106.
3. Bryant, F.B., Yarnold, P.R. Principal-components analysis and exploratory and confirmatory factor analysis. [Internet]. 1995 [cited 2015 Jul 28]. Available from http://psycnet.apa.org/psycinfo/1995-97110-004.
4. CDC. National Vital Statistics System Mortality Data - United States, 2001-2010 (Deaths) [Internet]. Available from: <. http://www.cdc.gov/traumaticbraininjury/data/rates_deaths_byage.html.
5. Clausen F., Hånell A., Björk M., Hillered L., Mir A.K., Gram H., et al. Neutralization of interleukin-1beta modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2009, 30:385-396.
6. Clausen F., Hånell A., Israelsson C., Hedin J., Ebendal T., Mir A.K., et al. Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2011, 34:110-123.
7. Crownover J., Galang G.N.F., Wagner A. Rehabilitation considerations for traumatic brain injury in the geriatric population: epidemiology, neurobiology, prognosis, and management. Curr. Trans. Geriatr. Exp. Gerontol. Rep. 2012, 1:149-158.
8. Daun S., Rubin J., Vodovotz Y., Clermont G. Equation-based models of dynamic biological systems. J. Crit. Care 2008, 23:585-594.
9. De Guise E., LeBlanc J., Dagher J., Tinawi S., Lamoureux J., Marcoux J., et al. Traumatic brain injury in the elderly: a level 1 trauma centre study. Brain Inj. 2015, 1-7.
10. Diamond M.L., Ritter A.C., Failla M.D., Boles J.A., Conley Y.P., Kochanek P.M., et al. IL-1β associations with posttraumatic epilepsy development: a genetics and biomarker cohort study. Epilepsia 2014, 55:1109-1119.
11. Ertel W., Keel M., Stocker R., Imhof H.G., Leist M., Steckholzer U., et al. Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury. J. Neuroimmunol. 1997, 80:93-96.
12. Failla M.D., Conley Y.P., Wagner A.K. Brain-derived neurotrophic factor (BDNF) in traumatic brain injury-related mortality: interrelationships between genetics and acute systemic and central nervous system BDNF profiles. Neurorehabil. Neural Repair 2015.
13. Friedland-Leuner K., Stockburger C., Denzer I., Eckert G.P., Müller W.E. Mitochondrial dysfunction: cause and consequence of Alzheimer's disease. Prog. Mol. Biol. Transl. Sci. 2013, 127:183-210.
14. Garringer J.A., Niyonkuru C., McCullough E.H., Loucks T., Dixon C.E., Conley Y.P., et al. Impact of aromatase genetic variation on hormone levels and global outcome after severe TBI. J. Neurotrauma 2013, 30:1415-1425.
15. Germann T., Gately M.K., Schoenhaut D.S., Lohoff M., Mattner F., Fischer S., et al. Interleukin-12/T cell stimulating factor, a cytokine with multiple effects on T helper type 1 (Th1) but not on Th2 cells. Eur. J. Immunol. 1993, 23:1762-1770.
16. Goyal A., Failla M.D., Niyonkuru C., Amin K., Fabio A., Berger R.P., et al. S100b as a prognostic biomarker in outcome prediction for patients with severe traumatic brain injury. J. Neurotrauma 2013, 30:946-957.
17. Grimm L.G., Yarnold P.R. Reading and Understanding Multivariate Statistics 1995, Internet, American Psychological Association, [cited 2015 Jul 28]. Available from:
18. Hallenbeck J.M. Prevention of postischemic impairment of microvascular perfusion. Neurology 1977, 27:3-10.
19. Hamilton M.A.X. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 1967, 6:278-296.
20. Hang C., Shi J., Tian J., Li J., Wu W., Yin H. Effect of systemic LPS injection on cortical NF-kappaB activity and inflammatory response following traumatic brain injury in rats. Brain Res. 2004, 1026:23-32.
21. Harrison-Felix C., Whiteneck G., DeVivo M., Hammond F.M., Jha A. Mortality following rehabilitation in the traumatic brain injury model systems of care. NeuroRehabil. Interdiscip. J. 2004, 19:45-54.
22. Hayakata T., Shiozaki T., Tasaki O., Ikegawa H., Inoue Y., Toshiyuki F., et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004, 22:102-107.
23. Helmy A., Antoniades C.A., Guilfoyle M.R., Carpenter K.L., Hutchinson P.J. Principal component analysis of the cytokine and chemokine response to human traumatic brain injury. PLoS ONE 2012, 7:e39677.
24. Jennett B., Bond M. Assessment of outcome after severe brain damage. Lancet 1975, 1:480-484.
25. Jeong H.-K., Ji K., Min K., Joe E.-H. Brain inflammation and microglia: facts and misconceptions. Exp. Neurobiol. 2013, 22:59-67.
26. Juengst S.B., Kumar R.G., Failla M.D., Goyal A., Wagner A.K. Acute inflammatory biomarker profiles predict depression risk following moderate to severe traumatic brain injury. J. Head Trauma Rehabil. 2014.
27. Kaiser H.F. The application of electronic computers to factor analysis. Educ. Psychol. Meas. 1960, Internet, [cited 2015 Jul 28]. Available from:
28. Kirchhoff C., Stegmaier J., Bogner V., Buhmann S., Mussack T., Kreimeier U., et al. Intrathecal and systemic concentration of NT-proBNP in patients with severe traumatic brain injury. J. Neurotrauma 2006, 23:943-949.
29. Kumar R., Boles J., Wagner A. Chronic inflammation characterization after severe TBI and associations with 6 and 12 month outcome. J. Head Trauma Rehabil. 2014.
30. Lourbopoulos A., Ertürk A., Hellal F. Microglia in action: how aging and injury can change the brain's guardians. Front. Cell. Neurosci. 2015, 9. Internet, [cited 2015 Nov 18] Available from:
31. Lucas S.-M., Rothwell N.J., Gibson R.M. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 2006, 147(Suppl. 1). S232-240.
32. Maas A.I.R., Roozenbeek B., Manley G.T. Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 2010, 7:115-126.
33. Machado R.F., Laskowski D., Deffenderfer O., Burch T., Zheng S., Mazzone P.J., et al. Detection of lung cancer by sensor array analyses of exhaled breath. Am. J. Respir. Crit. Care Med. 2005, 171:1286-1291.
34. MacQueen J., et al. Some methods for classification and analysis of multivariate observations [Internet]. In: Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability. Oakland, CA, USA.; 1967, pp. 281-297.[cited 2015 Jul 28]. Available from: <. https://books.google.com/books?hl=en%26lr=%26id=IC4Ku_7dBFUC%26oi=fnd%26pg=PA281%26dq=MacQueen+Some+methods+for+classification+and+analysis+of+multivariate+observations.+%26ots=nNVjC1NdrP%26sig=ihmF4o8sQBQeBYikUkbMs28lgiY.
35. Mocchegiani E., Costarelli L., Giacconi R., Malavolta M., Basso A., Piacenza F., et al. Vitamin E-gene interactions in aging and inflammatory age-related diseases: Implications for treatment. A systematic review. Ageing Res. Rev. 2014, 14:81-101.
36. Morganti-Kossman M.C., Lenzlinger P.M., Hans V., Stahel P., Csuka E., Ammann E., et al. Production of cytokines following brain injury: beneficial and deleterious for the damaged tissue. Mol. Psychiatry 1997, 2:133-136.
37. Nettleton J.A., Steffen L.M., Schulze M.B., Jenny N.S., Barr R.G., Bertoni A.G., et al. Associations between markers of subclinical atherosclerosis and dietary patterns derived by principal components analysis and reduced rank regression in the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2007, 85:1615-1625.
38. Norden D.M., Muccigrosso M.M., Godbout J.P. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease. Neuropharmacology 2014, [cited 2015 Nov 18]. Available from:
39. Pleines U.E., Stover J.F., Kossmann T., Trentz O., Morganti-Kossmann M.C. Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J. Neurotrauma 1998, 15:399-409.
40. Rappaport M., Hall K.M., Hopkins K., Belleza T., Cope D.N. Disability rating scale for severe head trauma: coma to community. Arch. Phys. Med. Rehabil. 1982, 63:118-123.
41. Røe C., Skandsen T., Anke A., Ader T., Vik A., Lund S.B., et al. Severe traumatic brain injury in Norway: impact of age on outcome. J. Rehabil. Med. 2013, 45:734-740.
42. Salminen L.E., Paul R.H. Oxidative stress and genetic markers of suboptimal antioxidant defense in the aging brain: a theoretical review. Rev. Neurosci. 2014, 25:805-819.
43. Santarsieri M., Kumar R.G., Kochanek P.M., Berga S., Wagner A.K. Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav. Immun. 2015, 45:15-27.
44. Sarle W.S. SAS technical report A-108. Cubic Cluster Criterion 1983, SAS Inst, Cary, NC.
45. Scherbel U., Raghupathi R., Nakamura M., Saatman K.E., Trojanowski J.Q., Neugebauer E., et al. Differential acute and chronic responses of tumor necrosis factor-deficient mice to experimental brain injury. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:8721-8726.
46. Shiozaki T., Hayakata T., Tasaki O., Hosotubo H., Fuijita K., Mouri T., et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 2005, 23:406-410.
47. Suhr D.D. Principal component analysis vs. exploratory factor analysis. SUGI 30 Proc. 2005: 203-230.
48. Tadevosyan-Leyfer O., Dowd M., Mankoski R., Winklosky B., Putnam S., McGrath L., et al. A principal components analysis of the autism diagnostic interview-revised. J. Am. Acad. Child Adolesc. Psychiatry 2003, 42:864-872.
49. Wagner A., McCullough E.H., Niyonkuru C., Ozawa H., Loucks T.L., Dobos J.A., et al. Acute serum hormone levels: characterization and prognosis after severe traumatic brain injury. J. Neurotrauma 2011, 28:871-888.
50. Wagner A.K., Kumar R.G., Conley Y., Kochanek P.K., Berga S. Multiple aromatization mechanisms influence mortality and CNS secondary injury profiles after severe TBI. J. Neurotrauma 2015, 32(12):A92. 10.1089/neu.2015.29000.abstracts.
51. Woodcock T., Morganti-Kossmann M.C. The role of markers of inflammation in traumatic brain injury. Front. Neurol. 2013, 4:18.
52. Xu, K., Puchowicz, M.A., Sun, X., LaManna, J.C., 2008. Mitochondrial dysfunction in aging rat brain following transient global ischemia. In: Oxygen Transport to Tissue XXIX. Springer, pp. 379-386.